266 related articles for article (PubMed ID: 33239656)
1. Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment.
Liu L; Yu Z; Cheng H; Mao X; Sui W; Deng S; Wei X; Lv J; Du C; Xu J; Huang W; Xia S; An G; Zhou W; Ma X; Cheng T; Qiu L; Hao M
Sci Rep; 2020 Nov; 10(1):20508. PubMed ID: 33239656
[TBL] [Abstract][Full Text] [Related]
2. Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1α/CCL3.
Wang Y; Gao A; Zhao H; Lu P; Cheng H; Dong F; Gong Y; Ma S; Zheng Y; Zhang H; Zhang Y; Xu J; Zhu X; Yuan W; Zhang X; Hao S; Cheng T
Leukemia; 2016 Sep; 30(9):1897-908. PubMed ID: 27109512
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
Bouchnita A; Eymard N; Moyo TK; Koury MJ; Volpert V
Am J Hematol; 2016 Jun; 91(4):371-8. PubMed ID: 26749142
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells.
Bruns I; Cadeddu RP; Brueckmann I; Fröbel J; Geyh S; Büst S; Fischer JC; Roels F; Wilk CM; Schildberg FA; Hünerlitürkoglu AN; Zilkens C; Jäger M; Steidl U; Zohren F; Fenk R; Kobbe G; Brors B; Czibere A; Schroeder T; Trumpp A; Haas R
Blood; 2012 Sep; 120(13):2620-30. PubMed ID: 22517906
[TBL] [Abstract][Full Text] [Related]
5. A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function.
Vallet S; Pozzi S; Patel K; Vaghela N; Fulciniti MT; Veiby P; Hideshima T; Santo L; Cirstea D; Scadden DT; Anderson KC; Raje N
Leukemia; 2011 Jul; 25(7):1174-81. PubMed ID: 21403648
[TBL] [Abstract][Full Text] [Related]
6. Derepression of the DNA Methylation Machinery of the
Yu L; Takai J; Otsuki A; Katsuoka F; Suzuki M; Katayama S; Nezu M; Engel JD; Moriguchi T; Yamamoto M
Mol Cell Biol; 2017 Apr; 37(8):. PubMed ID: 28069743
[TBL] [Abstract][Full Text] [Related]
7. Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma.
Li Y; Zheng Y; Li T; Wang Q; Qian J; Lu Y; Zhang M; Bi E; Yang M; Reu F; Yi Q; Cai Z
Oncotarget; 2015 Sep; 6(27):24218-29. PubMed ID: 26155942
[TBL] [Abstract][Full Text] [Related]
8. HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1.
Vandyke K; Zeissig MN; Hewett DR; Martin SK; Mrozik KM; Cheong CM; Diamond P; To LB; Gronthos S; Peet DJ; Croucher PI; Zannettino ACW
Cancer Res; 2017 Oct; 77(20):5452-5463. PubMed ID: 28855206
[TBL] [Abstract][Full Text] [Related]
9. CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease.
Dairaghi DJ; Oyajobi BO; Gupta A; McCluskey B; Miao S; Powers JP; Seitz LC; Wang Y; Zeng Y; Zhang P; Schall TJ; Jaen JC
Blood; 2012 Aug; 120(7):1449-57. PubMed ID: 22618707
[TBL] [Abstract][Full Text] [Related]
10. [Effect of CCL3 on osteoblast in myeloma bone disease].
Zhao S; Fu R; Liu H; Wang Y; Li L; Liu C; Zhang T; Ding S; Gao S; Ruan E; Qu W; Wang H; Wang X; Wu Y; Song J; Liu H; Guan J; Shao Z
Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):623-7. PubMed ID: 25052606
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.
Silvestris F; Cafforio P; Tucci M; Dammacco F
Blood; 2002 Feb; 99(4):1305-13. PubMed ID: 11830480
[TBL] [Abstract][Full Text] [Related]
12. CCR1 as a target for multiple myeloma.
Vallet S; Anderson KC
Expert Opin Ther Targets; 2011 Sep; 15(9):1037-47. PubMed ID: 21609295
[TBL] [Abstract][Full Text] [Related]
13. Regulation of GATA1 levels in erythropoiesis.
Gutiérrez L; Caballero N; Fernández-Calleja L; Karkoulia E; Strouboulis J
IUBMB Life; 2020 Jan; 72(1):89-105. PubMed ID: 31769197
[TBL] [Abstract][Full Text] [Related]
14. Endothelial Cell-Selective Adhesion Molecule Expression in Hematopoietic Stem/Progenitor Cells Is Essential for Erythropoiesis Recovery after Bone Marrow Injury.
Sudo T; Yokota T; Okuzaki D; Ueda T; Ichii M; Ishibashi T; Isono T; Habuchi Y; Oritani K; Kanakura Y
PLoS One; 2016; 11(4):e0154189. PubMed ID: 27111450
[TBL] [Abstract][Full Text] [Related]
15. MM-associated anemia: more than "crowding out" HSPCs.
Podar K
Blood; 2012 Sep; 120(13):2539-40. PubMed ID: 23019201
[No Abstract] [Full Text] [Related]
16. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
Menu E; De Leenheer E; De Raeve H; Coulton L; Imanishi T; Miyashita K; Van Valckenborgh E; Van Riet I; Van Camp B; Horuk R; Croucher P; Vanderkerken K
Clin Exp Metastasis; 2006; 23(5-6):291-300. PubMed ID: 17086356
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1.
Su S; Mukaida N; Wang J; Zhang Y; Takami A; Nakao S; Matsushima K
Blood; 1997 Jul; 90(2):605-11. PubMed ID: 9226160
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of causes for anemia in patients with multiple myeloma].
Rokicka-Piotrowicz M; Paszkowska M; Król M; Król M; Kuratowska Z
Pol Arch Med Wewn; 2000 Dec; 104(6):843-51. PubMed ID: 11424663
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow expression of CCL3 is not correlated with the extent of lytic bone lesions.
Cohen Y; Gutwein O; Garach-Jehoshua O; Bar-Haim A; Kornberg A
Acta Haematol; 2014; 132(2):129-33. PubMed ID: 24556596
[No Abstract] [Full Text] [Related]
20. [Involvement of apoptosis and proinflammatory cytokines in the pathogenesis of anemia in multiple myeloma].
Grzaśko N
Postepy Hig Med Dosw (Online); 2004; 58():364-71. PubMed ID: 15536394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
